ISSN 2490-3329 (Print)
ISSN 2303-7954 (Online)

Volume 49, Issue 2, Article 5

(Scr Med 2018:49:105-111)
ORIGINAL SCIENTIFIC ARTICLE

Complications of Diabetes Mellitus on Muscles and Joints of Lower Extremities

Snježana Novaković Bursać1, Slavica Jandrić2, Goran Talić1,2, Gordana Ljubojević1

1 Institute for physical medicine and rehabilitation „Dr Miroslav Zotović“
2 Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

 


DOI 10.7251/SCMED1802105B
UDC 616.379-008.64-06
COBISS.RS-ID 7837464

 


ABSTRACT

Introduction: Non-enzymatic protein glycosylation in diabetic patients leads to stiffening of collagen-containing tissues affecting joint mobility. Motor dysfunction in diabetic patients can be detected as muscle weakness or atrophy.

Objective: To determine the presence of muscles weakness and limited joint mobility at ankle (AJ), subtalar (SJ) and first metatarsophalangeal joint (I MTP) in diabetic patients and to determine impact of diabetes duration on those changes.

Patients and Methods: A cross-sectional study was conducted among 100 diabetic patients in “Primary Health Care Centre Banjaluka” in 2014. Function of ten foot and ankle muscles has been evaluated by manual muscle testing. Muscle strength was scored by semiquantitative grading system used in the Michigan Diabetic Neuropathy Score. Range of motion (ROM) at the AJ, SJ and I MTP was measured with goniometer.

Results: The average patients age was 61.91±10.74 and diabetes duration 12.25±8.60 years. The average strength of foot and ankle muscles expressed by muscle score was 11.56±5.08. The average ROM at AJ (47.85°) was significantly decreased compared to the reference value that is 65° (t =-15.378, P=000). The average ROM at SJ (35.10°) was significantly decreased compared to the reference value that is 50° (t =-15.378, P=000). The average ROM at the I MTP (72.70°) was significantly decreased compared to the reference value that is 120° (t =-15.378, P = ,000).

Conclusion: Patients with diabetes have decreased foot and ankle muscle strength, and the average values of the range of motion at AJ, SJ and I MTP, but the duration of the diabetes does not correlate significantly with those changes.

Key words: diabetes, muscle strength, range of motion

 

Pdf version of article

 

 

References:

1. International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium: International Diabetes Federation, 2015. http://www.diabetesatlas.org
2. International Diabetes Federation. International Working Group on the Diabetic foot. Diabetes and Foot Care: Time to Act 2005, Brussels, Belgium, 2005.
3. American Diabetes Association. Preventive foot care in diabetes. Diabetes Care 2004; 27(1):63-4.
4. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006;45(5):1-66.
5. Sartor CD, Watari R, Pássaro AC, Picon AP, Hasue RH, Sacco ICN. Effects of a combined strengthening, stretching and functional training program versus usual-care on gait biomechanics and foot function for diabetic neuropathy: a randomized controlled trial. BMC Musculoskelet Disord 2012;13:36.
6. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care 2004;27:942-46.
7. Giacomozzi C, D’Ambrogi E, Cesinaro S, Macellari V, Uccioli L.Muscle performance and ankle joint mobility in long-term patients with diabetes. BMC Musculoskelet Disord 2008;9:99. doi: 10.1186/1471-2474-9-99.
8. Abate M, Schiavone C, Salini V, Andia I. Management of limited joint mobility in diabetic patients. Diabetes Metab Syndr Obes 2013; 6:197–207.
9. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991;14(1):8-11.
10. Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev 2012;28 Suppl 1:89-92.
11. Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 2004; 27(10):2382-5.
12. Balducci S, Sacchetti M, Orlando G, Salvi L, Pugliese L, Salerno G, et al. Correlates of muscle strength in diabetes: The study on the assessment of determinants of muscle and bone strength abnormalities in diabetes (SAMBA). Nutr Metab Cardiovasc Dis 2014;24(1):18-26.
13. Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004;53(6):1543-8.
14. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006;55(3):806-12.
15. Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P, et al. Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech 2013;28(8):831-45.
16. Bakker K, Apelqvist J, Schaper NC; International Working Group on Diabetic Foot Editorial Board. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012;28(1):225-31.
17. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 2004;27(4):901-7.
18. Diabetes UK. London: State of the nation (England): challenges for 2015 and beyond. Available from: https://www.diabetes.org.uk/Documents/About%20Us/What%20we%20say/State%20of%20the%20nation%202014.pdf  [Accessed 3 March 2015].
19. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54(6):1615-25.
20. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG; A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22(7):1036-42.
21. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ; AusDiab Study Group. Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 2003;20:105–13.
22. van Schie CHM, Vermigli C, Carrington AL, Boulton A. Muscle weakness and foot deformities in diabetes: relationship to neuropathy and foot ulceration in caucasian diabetic men. Diabetes Care 2004;27:1668-73.
23. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17(11):1281-9.
24. Bokan V. Muscle weakness and other late complications of diabetic polyneuropathy. Acta Clin Croat 2011;50(3):351-5.
25. Lacote M. Chevalier AM, Miranda A, Bleton JP, Stevenin P. Clinical evaluation of muscle function. Edinburgh, London, Melbourn and New York: Churchill Livingstone, 1987.
26. Jandrić S. Osnovi fizikalne medicine i rehabilitacije. Laktaši: Grafomarkt; 2009.
27. Stevanović M, Stevanović M. Merenje obima pokreta u zglobovima. Beograd: Zavod za rehabilitaciju „Dr Miroslav Zotović“; 1975.
28. Magee DJ. Lower Leg, Ankle, and Foot. in Orthopedic Physical Assessment, 4th edition. Philadelphia, Pa: W.B.Saunders; 2002.
29. Camargo MR, Barela JA, Nozabieli AJ, Mantovani AM, Martinelli AR, Fregonesi CE. Balance and ankle muscle strength predict spatiotemporal gait parameters in individuals with diabetic peripheral neuropathy. Diabetes Metab Syndr 2015;9(2):79-84.
30. IJzerman TH, Schaper NC, Melai T, Meijer K, Willems PJ, Savelberg HH. Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life. Diabetes Res Clin Pract 2012;95(3):345-51.
31. Greenman RL, Khaodhiar L, Lima C, Dinh T, Giurini JM, Veves A. Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care 2005; 28(6):1425-30.
32. Sawacha Z, Spolaor F, Guarneri G, Contessa P, Carraro E, Venturin A, Avogaro A, Cobelli C. Abnormal muscle activation during gait in diabetes patients with and without neuropathy. Gait Posture 2012;35(1):101-5.
33. Yavuzer G, Yetkin I, Toruner FB, Koca N, Bolukbas N. Gait deviations of patients with diabetes mellitus: Looking beyond peripheral neuropathy. Eura Medicophys 2006; 42(2):127-33.
34. Wrobel JS, Najafi B. Diabetic Foot Biomechanics and Gait Dysfunction. J Diabetes Sci Technol 2010;4(4):833-45.
35. Muelle MJ, Diamond JE, Delitto A, Sinacore DR. Insensitivity, Limited Joint Mobility, and Plantar Ulcers in Patients with Diabetes Mellitus. Phys Ther 1989;69(6):453-9.
36. Matsui N, Shoji M, Kitagawa T, Terada S. Factors affecting the range of motion of the ankle and first metatarsophalangeal joints in patients undergoing hemodialysis who walk daily.J Phys Ther Sci 2016;28(5):1560–4.
37. Goldsmith JR, Lidtke RH, Shott S. The effects of range-of-motion therapy on the plantar pressures of patients with diabetes mellitus. J Am Podiatr Med Assoc 2002;92(9):483-90.
38. Turner DE, Helliwell PS, Burton AK, Woodburn J. The relationship between passive range of motion and range of motion during gait and plantar pressure measurements. Diabet Med 2007;24(11):1240-6.
39. Somai P. Limited Joint Mobility in Diabetes Mellitus: The Clinical Implications. Rheumatology Network 2011 March. Available from: http://www.rheumatologynetwork.com/articles/limited-joint-mobility-diabetes-mellitus-clinicalimplications . [Accessed 22 Nov 2016]
40. Rao S, Saltzman C, Yack HJ. Ankle ROM and stiffness measured at rest and during gait in individuals with and without diabetic sensory neuropathy. Gait Posture 2006; 24(3):295-301.
41. Shi L, Rui YF, Li G, Wang C. Alterations of tendons in diabetes mellitus: what are the current findings? Int Orthop 2015;39(8):1465-73.
42. Li Y, Fessel G, Georgiadis M, Snedeker JG. Advanced glycation end-products diminish tendon collagen fiber sliding. Matrix Biol 2013;32(3-4):169-77.
43. Hajrasouliha AR, Tavakoli S, Esteki A, Nafisi S, Noorolahi- Moghaddam H. Abnormal viscoelastic behaviour of passive ankle joint movement in diabetic patients: an early or a late complication? Diabetologia 2005;48(6):1225-8.
44. Sacco IC, Hamamoto AN, Gomes AA, Onodera AN, Hirata RP, Hennig EM Role of ankle mobility in foot rollover during gait in individuals with diabetic neuropathy. Clin Biomech 2009;24(8):687-92.
45. Sartor CD, Hasue RH, Cacciari LP, Butugan MK, Watari R, Pássaro AC, et al. Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: results of a randomized controlled trial. Musculoskelet Disord 2014;15:137. doi: 10.1186/1471-2474-15-137.
46. Nagawa MHB, Shawky AF, Basant H. Gait Analysis in Patients with Diabetic Peripheral Neuropathy. Med J Cairo Univ 2010;78(2):827-34.
47. Allet L, Armand S, de Bie RA, Golay A, Monnin D, Aminian K, et al. The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia 2010;53(3):458-66.
48. Wrobel JS, Najafi B. Diabetic Foot Biomechanics and Gait Dysfunction. J Diabetes Sci Technol 2010;4(4):833-45.


Corresponding author:
Snježana Novaković Bursać
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Manuscript received: September 17th, 2018
Manuscript accepted: August 6th, 2018